Related Experiment Video

Updated: Jul 28, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

[Drug prescription in the post-percutaneous coronary interventions period: results of the ECART study]

F Philippe1, A Sebaoun, C Avierinos

  • 1Département de pathologie cardiaque, institut mutualiste Montsouris, 42, boulevard Jourdan, 75014 Paris, France. francois.philippe@imm.fr

Annales De Cardiologie Et D'Angeiologie
|August 5, 2004
PubMed

Insights

The ECART study shows French cardiologists significantly increased statin and ACE inhibitor prescriptions post-PCI for coronary heart disease patients, improving secondary prevention. Antiplatelet use also rose, while nitrates decreased.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Context:

  • The ECART study examined drug prescription patterns among 1000 French cardiologists for 1041 patients with coronary heart disease (CAD).
  • Prescription data were collected before and after percutaneous coronary interventions (PCI).
  • This research addresses current therapeutic practices in secondary prevention of cardiovascular disease.

Purpose:

  • To investigate the impact of percutaneous coronary interventions (PCI) on medication prescribing habits in French cardiology practice.
  • To evaluate the adherence to evidence-based medicine guidelines for secondary prevention in patients with coronary heart disease.
  • To compare current drug prescription trends with historical data from similar patient populations.

Summary:

  • Baseline prescription rates for CAD patients included beta-blockers (96%), antiplatelets (85%), statins (56%), nitrates (36%), calcium blockers (26%), and ACE inhibitors (8.7%).
  • Following PCI, significant increases were observed in antiplatelet agents (to 97%), ACE inhibitors (to 29%), and statins (to 94%).
  • Nitrate prescriptions significantly decreased (to 23%), while calcium blocker rates remained stable at 26%.

Impact:

  • The findings highlight a positive shift towards guideline-recommended therapies, particularly statins and ACE inhibitors, post-PCI.
  • This study provides valuable insights into real-world drug prescription practices in secondary cardiovascular disease prevention.
  • Results contribute to the ongoing discussion on evidence-based medicine and optimization of pharmacotherapy in post-interventional CAD patients.

More Related Videos

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...